Literature DB >> 22364334

Insight and suicidal behavior in first-episode schizophrenia.

Ingrid Melle1, Elizabeth Ann Barrett.   

Abstract

Suicidal behavior and suicide is prevalent in schizophrenia, with an estimated lifetime risk of approximately 5%. The risk is particularly high in the early phases of the disorder, and especially during the years around treatment initiation. Suicide attempts before first treatment contact are also prevalent, with the risk of suicide attempt associated with the length of untreated illness. Several risk factors are in common with the general population, and include previous suicide attempts, impulsive personality traits, substance abuse, depression and feelings of hopelessness. Recent research examines how patients' subjective experiences, including their insight into having a severe mental illness and their beliefs about mental illnesses, may influence suicidal behavior. In this article, we will present a review of studies illustrating the complex background of suicide risk in schizophrenia, with a particular emphasis on the role of insight in the early phases of schizophrenia.

Entities:  

Mesh:

Year:  2012        PMID: 22364334     DOI: 10.1586/ern.11.191

Source DB:  PubMed          Journal:  Expert Rev Neurother        ISSN: 1473-7175            Impact factor:   4.618


  10 in total

Review 1.  The effects of aging on insight into illness in schizophrenia: a review.

Authors:  Philip Gerretsen; Eric Plitman; Tarek K Rajji; Ariel Graff-Guerrero
Journal:  Int J Geriatr Psychiatry       Date:  2014-07-23       Impact factor: 3.485

2.  Measuring insight through patient self-report: an in-depth analysis of the factor structure of the Birchwood Insight Scale.

Authors:  Sean D Cleary; Sanaa Bhatty; Beth Broussard; Sarah L Cristofaro; Claire Ramsay Wan; Michael T Compton
Journal:  Psychiatry Res       Date:  2014-02-06       Impact factor: 3.222

3.  Temperature elevation in epileptogenic foci exacerbates epileptic discharge through TRPV4 activation.

Authors:  Koji Shibasaki; Katsuya Yamada; Hideki Miwa; Yuchio Yanagawa; Michiyasu Suzuki; Makoto Tominaga; Yasuki Ishizaki
Journal:  Lab Invest       Date:  2019-10-22       Impact factor: 5.662

4.  Prosodic abnormalities in schizotypal personality disorder.

Authors:  Chandlee C Dickey; Mai-Anh T Vu; Martina M Voglmaier; Margaret A Niznikiewicz; Robert W McCarley; Lawrence P Panych
Journal:  Schizophr Res       Date:  2012-10-12       Impact factor: 4.939

5.  The "Insight Paradox" in Schizophrenia: Magnitude, Moderators and Mediators of the Association Between Insight and Depression.

Authors:  Martino Belvederi Murri; Mario Amore; Pietro Calcagno; Matteo Respino; Valentina Marozzi; Mattia Masotti; Michele Bugliani; Marco Innamorati; Maurizio Pompili; Silvana Galderisi; Mario Maj
Journal:  Schizophr Bull       Date:  2016-04-11       Impact factor: 9.306

6.  Suicidal Ideation and Schizophrenia: Contribution of Appraisal, Stigmatization, and Cognition.

Authors:  Emmanuel Stip; Jean Caron; Michel Tousignant; Yves Lecomte
Journal:  Can J Psychiatry       Date:  2017-07-04       Impact factor: 4.356

Review 7.  Risk Estimates and Risk Factors Related to Psychiatric Inpatient Suicide-An Overview.

Authors:  Trine Madsen; Annette Erlangsen; Merete Nordentoft
Journal:  Int J Environ Res Public Health       Date:  2017-03-02       Impact factor: 3.390

8.  Suicidality, self-stigma, social anxiety and personality traits in stabilized schizophrenia patients - a cross-sectional study.

Authors:  Kristyna Vrbova; Jan Prasko; Marie Ociskova; Michaela Holubova; Krystof Kantor; Antonin Kolek; Aleš Grambal; Milos Slepecky
Journal:  Neuropsychiatr Dis Treat       Date:  2018-06-01       Impact factor: 2.570

9.  Suicide Behavior and Its Predictors in Patients with Schizophrenia in Ethiopia.

Authors:  Mohammed Ayalew; Semira Defar; Yared Reta
Journal:  Schizophr Res Treatment       Date:  2021-04-01

10.  Suicide and suicide attempts in people with severe mental disorders in Butajira, Ethiopia: 10 year follow-up of a population-based cohort.

Authors:  Teshome Shibre; Charlotte Hanlon; Girmay Medhin; Atalay Alem; Derege Kebede; Solomon Teferra; Gunnar Kullgren; Lars Jacobsson; Abebaw Fekadu
Journal:  BMC Psychiatry       Date:  2014-05-23       Impact factor: 3.630

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.